🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/07/2010 | 33,18 | 33,84 | 32,84 | 33,81 | +2,25% | 2,99% | 17.699.882 |
| 06/07/2010 | 32,71 | 33,10 | 32,49 | 33,06 | +1,26% | 1,87% | 15.630.396 |
| 02/07/2010 | 32,88 | 32,92 | 32,11 | 32,65 | -0,64% | 2,47% | 17.809.188 |
| 01/07/2010 | 33,23 | 33,29 | 32,11 | 32,86 | -1,52% | 3,56% | 26.815.386 |
| 30/06/2010 | 33,70 | 33,72 | 33,16 | 33,37 | -1,30% | 1,67% | 22.218.753 |
| 29/06/2010 | 33,92 | 34,16 | 33,40 | 33,81 | -1,42% | 2,25% | 23.962.206 |
| 28/06/2010 | 34,48 | 34,48 | 33,94 | 34,29 | +0,03% | 1,58% | 14.404.341 |
| 25/06/2010 | 33,97 | 34,49 | 33,66 | 34,28 | +0,90% | 2,44% | 35.498.904 |
| 24/06/2010 | 33,57 | 34,06 | 33,56 | 33,98 | +0,54% | 1,51% | 17.217.592 |
| 23/06/2010 | 33,59 | 34,03 | 33,33 | 33,80 | +0,83% | 2,07% | 13.624.629 |
| 22/06/2010 | 33,58 | 34,08 | 33,46 | 33,52 | +0,03% | 1,85% | 17.187.095 |
| 21/06/2010 | 34,39 | 34,49 | 33,31 | 33,51 | -1,54% | 3,44% | 16.317.989 |
| 18/06/2010 | 34,26 | 34,35 | 33,86 | 34,04 | -0,53% | 1,45% | 20.582.510 |
| 17/06/2010 | 34,48 | 34,59 | 33,68 | 34,22 | -0,42% | 2,63% | 18.747.358 |
| 16/06/2010 | 34,07 | 34,52 | 34,06 | 34,36 | -0,03% | 1,34% | 18.167.394 |
| 15/06/2010 | 33,47 | 34,40 | 33,43 | 34,37 | +2,86% | 2,91% | 22.954.658 |
| 14/06/2010 | 33,44 | 33,64 | 33,35 | 33,42 | +0,46% | 0,86% | 14.311.802 |
| 11/06/2010 | 32,78 | 33,49 | 32,66 | 33,26 | +0,61% | 2,53% | 18.989.865 |
| 10/06/2010 | 32,58 | 33,19 | 32,43 | 33,06 | +2,79% | 2,31% | 19.612.901 |
| 09/06/2010 | 32,31 | 32,57 | 31,96 | 32,17 | -0,30% | 1,89% | 13.463.761 |
| 08/06/2010 | 31,88 | 32,32 | 31,58 | 32,26 | +1,50% | 2,30% | 16.223.983 |
| 07/06/2010 | 31,67 | 31,98 | 31,58 | 31,78 | +0,42% | 1,27% | 14.809.288 |
| 04/06/2010 | 32,30 | 32,37 | 31,48 | 31,65 | -3,27% | 2,75% | 19.078.316 |
| 03/06/2010 | 32,85 | 32,98 | 32,43 | 32,72 | -0,20% | 1,66% | 13.739.385 |
| 02/06/2010 | 32,09 | 32,81 | 31,99 | 32,79 | +2,48% | 2,53% | 16.971.522 |
| 01/06/2010 | 31,90 | 32,46 | 31,78 | 31,99 | -0,47% | 2,12% | 21.756.061 |
| 28/05/2010 | 32,10 | 32,56 | 31,97 | 32,15 | +0,21% | 1,84% | 26.192.454 |
| 27/05/2010 | 31,41 | 32,13 | 31,28 | 32,08 | +3,70% | 2,70% | 32.049.098 |
| 26/05/2010 | 30,52 | 31,35 | 30,38 | 30,94 | +1,12% | 3,16% | 27.518.803 |
| 25/05/2010 | 29,87 | 30,61 | 29,68 | 30,59 | +0,63% | 3,13% | 21.679.766 |